Takeda, AstraZeneca Sue Apotex Over Generic COPD Drug
Apotex Inc. infringed Takeda and AstraZeneca's patent for the chronic obstructive pulmonary disease drug Daliresp with a filing to the U.S. Food and Drug Administration declaring its intent to market a...To view the full article, register now.
Already a subscriber? Click here to view full article